These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15876908)

  • 41. Feeling unreal: a depersonalization disorder update of 117 cases.
    Simeon D; Knutelska M; Nelson D; Guralnik O
    J Clin Psychiatry; 2003 Sep; 64(9):990-7. PubMed ID: 14628973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study.
    Grant JE; Odlaug BL; Schreiber LR; Kim SW
    J Clin Psychopharmacol; 2014 Feb; 34(1):134-8. PubMed ID: 24145220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder.
    Sierra M; Phillips ML; Ivin G; Krystal J; David AS
    J Psychopharmacol; 2003 Mar; 17(1):103-5. PubMed ID: 12680746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].
    Ponce G; Sánchez-García J; Rubio G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Palomo T
    Actas Esp Psiquiatr; 2005; 33(1):13-8. PubMed ID: 15704026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.
    Lee JD; Friedmann PD; Boney TY; Hoskinson RA; McDonald R; Gordon M; Fishman M; Chen DT; Bonnie RJ; Kinlock TW; Nunes EV; Cornish JW; O'Brien CP
    Contemp Clin Trials; 2015 Mar; 41():110-7. PubMed ID: 25602580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
    Bosco D; Plastino M; Colica C; Bosco F; Arianna S; Vecchio A; Galati F; Cristiano D; Consoli A; Consoli D
    Clin Neuropharmacol; 2012; 35(3):118-20. PubMed ID: 22426027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts.
    Miotto K; McCann MJ; Rawson RA; Frosch D; Ling W
    Drug Alcohol Depend; 1997 Apr; 45(1-2):131-4. PubMed ID: 9179515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lamotrigine in the treatment of resistant depersonalization disorder: A case report].
    Bout A; Berhili N; Benbrahim M; Aalouane R; Rammouz I
    Encephale; 2018 Feb; 44(1):85-87. PubMed ID: 28602528
    [No Abstract]   [Full Text] [Related]  

  • 50. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
    Dannon PN; Lowengrub K; Musin E; Gonopolski Y; Kotler M
    J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Low dose naltrexone in the treatment of dissociative symptoms].
    Pape W; Wöller W
    Nervenarzt; 2015 Mar; 86(3):346-51. PubMed ID: 25421416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
    Rana F; Gormez A; Varghese S
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
    Haney M; Ramesh D; Glass A; Pavlicova M; Bedi G; Cooper ZD
    Neuropsychopharmacology; 2015 Oct; 40(11):2489-98. PubMed ID: 25881117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD001333. PubMed ID: 16437431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients.
    Timäus C; Meiser M; Wiltfang J; Bandelow B; Wedekind D
    Hum Psychopharmacol; 2021 Nov; 36(6):e2800. PubMed ID: 34029405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.
    Bisaga A; Sullivan MA; Glass A; Mishlen K; Pavlicova M; Haney M; Raby WN; Levin FR; Carpenter KM; Mariani JJ; Nunes EV
    Drug Alcohol Depend; 2015 Sep; 154():38-45. PubMed ID: 26187456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials.
    Streeton C; Whelan G
    Alcohol Alcohol; 2001; 36(6):544-52. PubMed ID: 11704620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.